(19)

(11)

EP 4 401 650 A1

(12)

(43) Date of publication: 24.07.2024 Bulletin 2024/30 (21) Application number: 22851099.6 (22) Date of filing: 09.12.2022

(51) International Patent Classification (IPC):  A61B 17/132(2006.01) G01L 1/04(2006.01) A61B 90/00(2016.01) G01G 23/00(2006.01) (52) Cooperative Patent Classification (CPC): A61B 90/08; A61B 2090/0807; A61B 2090/064; A61B 17/1322; A61B 2017/00115; G01G 23/20; G01L 1/042 (86) International application number: PCT/US2022/052398 (87) International publication number: WO 2023/107691 (15.06.2023 Gazette 2023/24)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 09.12.2021 US 202163287867 P (71) Applicant: Biolife L.L.C. Sarasota, Florida 34243 (US)	(72) Inventors: KEENE, Talmadge, Kelly Ruskin, FL 33570 (US) VADELUND, Kurt Apollo Beach, FL 33572 (US) (74) Representative: Marks & Clerk LLP  15 Fetter Lane London EC4A 1BW London EC4A 1BW (GB)